The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Here's how much Ozempic and similar drugs have soared in popularity since 2018 )
Also on site :
- Trump plan for fast-tracking nuclear power takes aim at regulators
- Freedom of the Press Foundation Threatens Legal Action if Paramount Settles With Trump Over '60 Minutes' Interview
- $53 Billion Guyana Oil Clash Heads to London Tribunal